纖體天成體重管理與代謝手術中心Weight Loss and Metabolic Surgery Center
纖體天成體重管理與代謝手術中心Weight Loss and Metabolic Surgery Center
Weight management is not about a number on the scale, it's about the full metabolic picture. Two people with the same BMI and the same body fat percentage can have completely different underlying conditions: one is a straightforward case of energy imbalance; another has PCOS, hypothyroidism, or elevated cortisol working in the background. Without the right assessment, treatment decisions are guesswork.
When patients come in and ask "what tests do I need?", I turn the question around: what do you want to know? Testing isn't a set menu, more isn't better. Every test should have a specific question it's designed to answer: "Is there a hidden cause behind this obesity?" or "Is it safe for this person to undergo this treatment?" Without a clear question, you just end up with a pile of numbers.
Most people expect obesity-related testing to mean a blood draw, a body fat scan, and a BMI calculation. Those are done, but they're only the beginning. In bariatric medicine, assessment serves two distinct purposes. Missing either one compromises the quality of the treatment decision.
Purpose one: identify whether there's a hidden cause behind the obesity. Most cases involve a combination of caloric intake and lifestyle factors, but not all. Polycystic ovary syndrome (PCOS), hypothyroidism, Cushing's syndrome, and pituitary conditions can all cause weight to accumulate in a way that's distinct from typical obesity, and requires a different treatment direction. Without this layer of assessment, a patient can spend years being managed as "general obesity" when the underlying issue is hormonal and requires endocrine specialist input first.
Purpose two: assess whether the patient can safely tolerate the proposed treatment. Whether the treatment is GLP-1 medication, endoscopic sleeve gastroplasty, or metabolic surgery, each has its own indications and contraindications. Cardiopulmonary capacity, liver and kidney function, nutritional reserves, and anesthesia risk all need to be known before treatment begins.
"Testing isn't a menu to order from, it's what makes treatment decisions precise. One unnecessary test is waste. One missing test is risk."
I've seen many patients arrive with thick folders of test results from other clinics, asking me "do these mean I should have surgery?" After reviewing them, I've said more than once: you've done a lot of tests, but you're missing several of the ones that would actually change the clinical decision, and a few of these expensive advanced scans are completely irrelevant to your situation. The value of testing is never in the volume. It's in whether the right questions are being answered.
Blood work, endocrine evaluation, and abdominal imaging, each answers a different layer of clinical questions.
Note: the following explains the purpose and scope of each category. Which specific tests are ordered, and in what sequence, is determined by Dr. Ser based on your individual clinical picture.
The most fundamental tool, and the one that most directly reflects what metabolic state the body is currently in.
This is not just cholesterol and blood sugar. The more important signals are insulin resistance, chronic inflammation markers, and baseline liver and kidney function. These numbers directly affect the answers to "should we intervene?", "how?", and "at what intensity?"
Typically includes:
Not everyone needs this layer, but when it's indicated and missed, the clinical consequence is significant.
Dr. Ser assesses whether deeper endocrine evaluation is warranted based on your symptoms, fat distribution pattern, menstrual history, comorbidities, and family history. Obesity caused by endocrine dysregulation requires a different treatment direction from typical obesity. PCOS requires simultaneous management of insulin resistance and androgens; hypothyroidism needs thyroid hormone restoration before weight loss can be addressed.
May be assessed depending on individual presentation:
Abdominal ultrasound is the primary tool, examining the liver and biliary system.
Obesity and fatty liver are closely linked. Early-stage fatty liver has no symptoms, blood tests can only indicate liver enzyme elevation, not what the liver actually looks like. Gallstone prevalence is also elevated in patients with obesity, particularly after rapid weight loss. Pre-surgical imaging assessment affects both the surgical approach and timing.
Primarily assesses:
On endocrine evaluation: I assess this not because I'm trying to do an endocrinologist's work, but because obesity and endocrine dysfunction are often two aspects of the same underlying condition. Looking at them separately misses the point. If assessment shows that your situation needs to be handled by endocrinology first, I'll refer you, not because I'm unwilling to operate, but because that's the correct clinical judgment for your specific case.
The three categories above apply to the initial evaluation phase, establishing baseline and identifying what needs to be addressed first. Once a patient enters the post-surgical phase, the focus shifts entirely.
Question being answered: Are there hidden causes behind this obesity? What treatment direction is appropriate?
Primary tests: The three categories above, blood work, endocrine evaluation, abdominal imaging. Goal: establish a baseline and identify conditions that need to be addressed before treatment begins.
Question being answered: Is nutritional status keeping up? Are the body's reserves holding?
Primary tests: Comprehensive nutritional monitoring panel, tracked at regular intervals. Surgery alters how the body absorbs nutrients, this layer of monitoring is non-negotiable and continues for many years.
Post-surgical nutritional monitoring, standard panel (12+ items)
These are not checked once before surgery and forgotten. They are tracked at regular intervals post-operatively. Bariatric surgery doesn't only change body weight, it changes the relationship between your body and nutrients. This monitoring continues for years.
When treatment enters the level of GLP-1 medication, endoscopic sleeve gastroplasty, or metabolic surgery, assessment takes on a second dimension beyond "what's behind the obesity." The question becomes: "can this person safely tolerate this treatment?"
This layer evaluates: cardiopulmonary capacity, anesthetic risk, nutritional reserves, and psychological readiness. Each form of treatment disturbs the body in some way, medications carry side effects to be managed, surgery involves anesthesia and a recovery period, and the post-surgical dietary structure changes significantly. If the body is already in a state of nutritional deficiency, anemia, or borderline cardiac or pulmonary function before treatment begins, the risk of the treatment itself is amplified.
Psychological readiness is also part of this assessment. Metabolic surgery is not "lie down, wake up thinner." It requires long-term follow-up, dietary adjustment, and navigating the psychological experience of rapid body change. If the mental groundwork isn't in place, treatment outcomes are diminished and complication risk rises.
Specific assessment items, test sequences, and timing are arranged by the team on an individual basis during your consultation. For a more detailed look at the surgical process, see the Surgery Q&A page.
"Pre-treatment assessment isn't a hurdle. It's protection. I want you to be living better after treatment, not just lighter."
Some tests are heavily marketed in the weight loss industry, packaged to look scientific, but with limited clinical utility. These are the ones I'll tell patients directly: you don't need this.
You may have seen "weight loss genetic testing" offered at other clinics, claiming to analyze which diet suits you, which exercise, where you tend to accumulate fat. My position is direct: I can order this test, but you need a concrete reason to do it.
International obesity treatment guidelines (including those from the American, European, and Asian bariatric surgery societies) do not list genetic testing as a basis for pre-surgical decision-making. The treatment direction for most common obesity presentations is established through history, lifestyle assessment, blood work, and targeted endocrine or imaging evaluation when indicated. A genetic report showing "tendency to gain weight" or "tendency to accumulate abdominal fat" has limited weight in clinical decision-making, treatment strategy is determined by your BMI, comorbidities, what approaches have been tried, and body system assessment. Not a single genotype.
That said, clinical decisions don't only come down to medical necessity. If you've had long-standing uncertainty about your metabolic constitution, and doing the test would give you confidence and motivation to commit to treatment, then it has value for you. In that case, I'm willing to arrange it.
CT, MRI, PET-CT, these are powerful tools for the specific clinical problems they're designed to address. Used as a "full-body sweep to look for causes of obesity," they're generally over-investigation.
Most of what bariatric medicine needs to answer can be addressed through blood work, abdominal ultrasound, and targeted endocrine testing where indicated. If initial assessment points toward a need for deeper imaging, that should absolutely be done, but "let's do it first and see" doesn't improve treatment precision. It redirects time and cost toward results that have no clinical bearing on your case.
Some patients arrive with thick stacks of results from multiple clinics, assuming that more data makes the picture clearer. Usually, the opposite is true: data without a clinical question as its anchor tends to mislead rather than inform.
A glucose result from a non-fasting draw, a female hormone panel taken at the wrong point in the menstrual cycle, an inflammatory marker done during an acute illness, these numbers, stripped of their clinical context, can obscure what actually deserves attention. The value of a test is always tied to the question it was designed to answer.
I write this because I've seen too many patients spend money outside, do a series of impressive-looking tests, and end up receiving treatment recommendations no different from what a general nutritionist would have given them. I'd rather you keep that money for tests that genuinely affect the clinical judgment, and for treatment that creates lasting improvement.
Practical questions about costs, existing reports, fasting, process, and more.
A meaningful remote consultation requires an actual clinical picture, not just a weight and BMI. The more complete the information you bring, the more concrete the assessment can be. Here's what to prepare:
Recommended preparation for remote consultation
Fasting blood work, done within the last 3 months
The most important: fasting glucose, HbA1c, fasting insulin, HOMA-IR, lipid panel (total cholesterol, triglycerides, LDL, HDL), liver function (ALT, AST, GGT), kidney function, uric acid. If available: hs-CRP, Vitamin D, B12, ferritin/iron.
Abdominal ultrasound report, within the last 1 year
Liver, gallbladder, kidneys. Most health check ultrasounds cover this. Bring the original report, "grade 2 fatty liver" is more useful than a verbal summary.
Current height, weight, waist circumference
Measured on the same day as the consultation if possible. A recent photo (front and side) is also helpful if you're comfortable sharing one.
Current medications and supplements, full list
Include dosages and how long you've been taking them. This affects which additional tests may be needed and which are already partially answered.
Endocrine reports, if you have them
Thyroid function (TSH, T3/T4), sex hormones, PCOS-related panels. If you've been diagnosed with a hormonal condition, bring the records and current treatment notes.
Weight history and prior approaches
Approximate weight at key life stages. What weight loss methods you've tried, for how long, and what happened. This context significantly changes the clinical picture.
Relevant comorbidities and family history
Diabetes, hypertension, dyslipidemia, sleep apnea, PCOS, fatty liver, gout, any condition you've been diagnosed with. Family history of diabetes, cardiovascular disease, or obesity-related conditions.
If you don't have some of these, bring what you have. The consultation will help identify what gaps need to be filled before treatment planning can proceed, either with tests arranged locally or after arriving in Taiwan.
Yes, please bring them. Here's how they're evaluated:
Abdominal imaging (ultrasound, other imaging reports): anatomical findings are more stable, within 1 year is generally usable, unless there's a specific new clinical question.
Bringing something is always better than not bringing it. Even older results establish your historical trajectory.
Yes, fasting is required. The standard is 8–10 hours without eating before the draw (water is fine).
The simplest approach: finish dinner the evening before, drink only water after that, and draw blood the following morning.
The reason: blood glucose, triglycerides, and fasting insulin are all affected by food intake. Without fasting, these results are uninterpretable, the draw is wasted.
Special situations:
The ideal process involves 2 visits:
First visit (~30 minutes): Consultation + blood draw + imaging referral. If you fast the night before, the blood draw can happen on the same day. If not, a second fasting visit is arranged.
Imaging (separately scheduled): Abdominal ultrasound, and FibroScan if indicated, through the hospital imaging department.
Second visit (~30 minutes, 1–2 weeks after blood work): Full report review and treatment direction discussion. All results are reviewed together, current status of your body systems, what needs to be addressed first, and what the treatment pathway looks like.
Overall timeline: approximately 2–3 weeks, across 2–3 visits. If further endocrine evaluation is needed, one additional blood draw is added.
Not necessarily, it's determined by clinical judgment. Endocrine testing is not a standard add-on for everyone. The decision is based on:
Men can also need this: obesity-related hypogonadism (low testosterone) is not uncommon in men and may be assessed.
If your basic blood work is unremarkable, fat distribution is uncomplicated, and there are no specific symptoms, the endocrine panel may not be necessary. Avoiding unnecessary testing is also part of clinical judgment.
Not necessarily a full panel re-run, but a directional update will be done:
Core principle: Don't repeat tests that have no additional meaning. But don't assume a past result is current, key markers get updated when clinically indicated.
Yes, but the complete interpretation is done in the consultation.
You can send reports in advance via WhatsApp or email to the case manager, who can flag any particularly notable values and advise on next steps. But a complete clinical interpretation needs to happen in consultation, because reading a report isn't just "this number is outside range." It requires your body composition, symptoms, medication history, and family history together. That context can't be properly assembled over a message.
If you're anxious after receiving results and want a preliminary read, send them in. But the clinical judgment is done in the consultation, not over chat.
Yes, bring it, I'll look at it, but it won't be the primary basis for treatment decisions.
My position on genetic testing is stated in the misconceptions section above: it has a place, but it isn't a required pre-treatment assessment item.
If you've already done it, I'll:
In short: worth bringing, but don't expect it to significantly change direction.
Within 1 year, most health check ultrasounds can be used.
Health check ultrasounds typically cover liver, gallbladder, pancreas, spleen, and kidneys. Anatomical findings (fatty liver grade, gallstones, cysts) don't change quickly, within 1 year is generally acceptable.
Situations where a re-scan may be recommended:
Please bring the complete report. It will be reviewed item by item, and you'll be told what's usable and what needs to be supplemented.
No. The purpose of assessment is to give you an accurate picture of your body's current state, not to funnel everyone into a surgical pathway.
Discovering a metabolic condition opens up a range of treatment options, not a single one:
The specific path depends on the full clinical picture, your BMI, comorbidity severity, what you've tried before, and your own goals and preferences. That's the conversation we have at the second consultation, after all results are in.
Whether you're coming in person or beginning with a remote consultation, the first step is the same, a clear look at where things actually stand.
Mon – Sat clinic hours · WhatsApp: +886 920-190-056
● Regular session · Appt By appointment only
Dr. Ser may occasionally be unavailable due to conferences. Please call to confirm before your visit.
Closed on national holidays.
Ten Chan Hospital · General Building, 3F
No. 155 Yanping Road, Zhongli District, Taoyuan City, Taiwan